comparemela.com

Latest Breaking News On - International drug monitoring - Page 2 : comparemela.com

WHO database is not proof that COVID-19 vaccines are harmful – Poynter

The health agency stresses the info presented in its databases does not prove a definitive link between the reported side effects and the vaccines.

150,000 American deaths from the Covid vaccine?

150,000 American deaths from the Covid vaccine?
freerepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freerepublic.com Daily Mail and Mail on Sunday newspapers.

Lawsuit Brings Renewed Attention to Finasteride Adverse Events

Lawsuit Brings Renewed Attention to Finasteride Adverse Events
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

COVID-19 vaccines safe, effective – FDA assures public

705 The Food and Drugs Authority (FDA) says adequate safety and quality assurance has been done in authorising the two COVID-19 vaccines to be administered in the country. It said no safety and efficacy standards were bypassed or compromised, except that the emergency use authorisation pathway allowed for expedited review for the public good. Assurance Giving the assurance in an interview with the Daily Graphic in Accra yesterday, the Chief Executive Officer (CEO) of the FDA, Mrs Delese Mimi Darko, said the two vaccines were Covishield, AstraZeneca Vaccine, manufactured by Serum Institute of India, and Sputnik-V, manufactured by Generium in Russia.

Darnitsa digitalizes its pharmacovigilance system to meet the requirements of foreign regulators

Darnitsa digitalizes its pharmacovigilance system to meet the requirements of foreign regulators 3 min read Darnitsa pharmaceutical company is developing its pharmacovigilance system, its digitalization allowing the company to meet the modern requirements of foreign regulators, said Head of the Department for Regulatory Issues of Darnitsa Oleksandr Torhun. ‘The modern system of pharmacovigilance will allow Darnitsa in the long term to successfully meet the demands of those regulators that require more extensive data for registration dossiers. In fact, we are proactive in this case. After all, the capabilities of the new system are much wider than the classic format of pharmacovigilance,” the press service of the company quotes Torhun.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.